Free Daily Biotech Industry Newsletter
Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 150,000 biotech professionals who subscribe to FierceBiotech for FREE!
Shares of Cleveland BioLabs ($CBLI) were trounced yesterday as word spread that a division of Health and Human Services had turned a cold shoulder to its experimental treatment for radiation poisoning.
| Tuesday, June 23 | 11:00am ET / 8:00am PT | Presented By: MWV Healthcare
This webinar will address the impact of medication non-adherence in clinical trials. Accurate adherence measurement is necessary to evaluate a compound's true potential and increase the likelihood of a successful trial outcome. Register today!
FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 150,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!